Vancomycin Exposure Does Not Elicit Detectable Vancomycin‐Specific IgG
- 10 November 2026
- journal article
- research article
- Published by Wiley in Clinical & Experimental Allergy
Abstract
Summary: Vancomycin‐specific IgG was undetectable in exposed subjects with or without prior reaction, suggesting that vancomycin is poorly immunogenic. Absence of drug‐specific antibody does not imply a milder reaction or lower clinical risk.Keywords
Funding Information
- American Academy of Allergy, Asthma and Immunology Foundation (2023‐1)
This publication has 9 references indexed in Scilit:
- Assessment of Patients With Beta‐Lactams Positive Provocation Tests by Biomarkers of IgG ‐Related Neutrophil ActivationClinical & Experimental Allergy, 2025
- A Skin Testing Strategy for Non–IgE-Mediated Reactions Associated With VancomycinThe Journal of Allergy and Clinical Immunology: In Practice, 2024
- Non–IgE-Mediated Immediate Drug-Induced Hypersensitivity ReactionsThe Journal of Allergy and Clinical Immunology: In Practice, 2024
- Anti-PEG IgE in anaphylaxis associated with polyethylene glycolThe Journal of Allergy and Clinical Immunology: In Practice, 2021
- Vancomycin immediate skin responses in vancomycin‐naïve subjectsClinical & Experimental Allergy, 2021
- Vancomycin Hypersensitivity Reactions Documented in Electronic Health RecordsThe Journal of Allergy and Clinical Immunology: In Practice, 2020
- An IgG-induced neutrophil activation pathway contributes to human drug-induced anaphylaxisScience Translational Medicine, 2019
- Immune-mediated reactions to vancomycinAnnals of Allergy, Asthma & Immunology, 2016
- Prevalence of Antimicrobial Use in US Acute Care Hospitals, May-September 2011JAMA, 2014